Solel to upgrade 7 US power plants

Solel also said it has completed development of its Solel 6 system, which uses parabolic troughs to concentrate solar energy and produces 50% more energy than previous models.

By DANIEL KENNEMER
June 14, 2006 09:39

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Beit Shemesh-based Solel won a contract to upgrade seven solar plants in California owned and operated by FPL Energy. The company's spokesman said the deal to supply FPL with 48,000 of Solel's third-generation thermo-solar collection units was worth "several tens of millions of dollars." Solel also said it has completed development of its Solel 6 system, which uses parabolic troughs to concentrate solar energy and produces 50% more energy than previous models. Separately, Netanya-based Solar Power unveiled a new system for pivoting photovoltaic panels to aim them at the sun throughout the day, which would increase production capacity by 30%-60%.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS